Ranking Profile - Navidea Biopharmaceuticals Inc

Introduction

Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics. Its pipeline products include Tc99m tilmanocept for Kaposi's, NAS, Cardiovascular diseases, Sentinal Node Biopsy, and Solid tumors lymphatic mapping; and NAV4694 for Alzheimer's Disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to improve patient care by identifying pathways and sites of undetected diseases and allowing clinical decision-making and diagnostic accuracy. The company has a presence in the US, and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Company info

Country (HQ): United States
Sector: Pharmaceuticals and Healthcare
Market Cap (US$ m): 4
Revenue (US$ m): 0.07 (2022)

Innovation ranking

338

Innovation score

Closest peers in the Pharmaceuticals and Healthcare sector

Innovation Ranking

Company
Headquarters
Sector

Johnson & Johnson

United States

Pharmaceuticals and Healthcare

F. Hoffmann-La Roche Ltd

Switzerland

Pharmaceuticals and Healthcare

Navidea Biopharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

EyeGate Pharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

Shin Poong Pharm Co Ltd

South Korea

Pharmaceuticals and Healthcare

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers